About
Neuvogen is a biotechnology company developing therapeutic whole cell cancer vaccines to treat solid tumors by addressing tumor complexity and heterogeneity.
Explore Neuvogen's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.